Market Exclusive

Analyst Upgrades – Momenta Pharmaceuticals (NASDAQ:MNTA) Stock Gets Upgraded By Stifel Nicolaus from Hold to Buy

Analyst Ratings For Momenta Pharmaceuticals (NASDAQ:MNTA)

Today, Momenta Pharmaceuticals (NASDAQ:MNTA) stock received an upgrade by Stifel Nicolaus from Hold to Buy with a price target of $21.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Momenta Pharmaceuticals (NASDAQ:MNTA)
Momenta Pharmaceuticals (NASDAQ:MNTA) has insider ownership of 4.40% and institutional ownership of 95.43%.

Recent Trading Activity for Momenta Pharmaceuticals (NASDAQ:MNTA)
Shares of Momenta Pharmaceuticals closed the previous trading session at 17.00 up +0.65 3.98% with 17.0 shares trading hands.

Exit mobile version